Subtype
Uterine Corpus Smooth Muscle Neoplasm
CI-CAN-00004202Explore in graph →
Non-malignant43 active trials
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004202Explore in graph →
Clinical trials
315 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00341848 | Postpartum Uterine Regression | completed | — | 374 | National Institute of Environmental Health Sciences (NIEHS)NIH | 1 | Jun 17, 2019 | clinicaltrials |
| NCT03072446 | Uterine Fibroid Embolization (UFE) for Symptomatic Fibroids: Comparison of Gel-Bead to Commonly Used Embolic Agents. | completed | N/A | 11 | University Hospital Southampton NHS Foundation TrustOTHER | 1 | May 9, 2019 |
| NCT02914704 | Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) | unknown | N/A | 500 | Turku University HospitalOTHER_GOV | 1 | Apr 29, 2019 | clinicaltrials |
| NCT03904368 | The Value of Myomectomy in Women With Intramural Myoma Before IVF. | unknown | N/A | 100 | Cairo UniversityOTHER | 1 | Apr 5, 2019 | clinicaltrials |
| NCT02655224 | A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids | completed | Phase 3 | 65 | TakedaINDUSTRY | 1 | Mar 22, 2019 | clinicaltrials |
| NCT02655237 | A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids | completed | Phase 3 | 281 | TakedaINDUSTRY | 1 | Mar 22, 2019 | clinicaltrials |
| NCT01142791 | Safety Study of ExAblate for the Treatment of Uterine Fibroids | completed | N/A | 121 | InSightecINDUSTRY | 1 | Mar 19, 2019 | clinicaltrials |
| NCT01285960 | ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids | completed | N/A | 108 | InSightecINDUSTRY | 1 | Mar 6, 2019 | clinicaltrials |
| NCT02879058 | Intraoperative Ultrasound in Laparoscopic or Robotic Myomectomy Patients | terminated | N/A | 140 | The Cleveland ClinicOTHER | 1 | Mar 4, 2019 | clinicaltrials |
| NCT03792009 | Paracervical Block in Laparoscopic Hysterectomy(PALAPA) | unknown | N/A | 86 | Kangbuk Samsung HospitalOTHER | 1 | Feb 25, 2019 | clinicaltrials |
| NCT03847077 | Trial of a Patient Education Tool For Leiomyoma(PETAL) | completed | N/A | 72 | Loyola UniversityOTHER | 0 | Feb 20, 2019 | clinicaltrials |
| NCT00365989 | MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication | completed | Phase 3 | 50 | InSightecINDUSTRY | 2 | Feb 5, 2019 | clinicaltrials |
| NCT03349190 | Impact of Esmya on Fertility to Infertile Women With Fibroids Managed With Assisted Reproduction Techniques(NACRE) | completed | — | 127 | ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITROOTHER | 2 | Jan 9, 2019 | clinicaltrials |
| NCT00295217 | MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 Validation | completed | Phase 3 | 15 | InSightecINDUSTRY | 1 | Dec 20, 2018 | clinicaltrials |
| NCT01750008 | Laparoscopic Uterine Sparing Techniques Outcomes and Reinterventions(LUSTOR) | completed | N/A | 51 | Acessa Health, Inc.INDUSTRY | 1 | Nov 20, 2018 | clinicaltrials |
| NCT02942537 | Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment(MYOMIC1) | unknown | Phase 2 / Phase 3 | 36 | Karolinska InstitutetOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT02472184 | Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy | completed | N/A | 78 | University of South FloridaOTHER | 1 | Sep 26, 2018 | clinicaltrials |
| NCT03586947 | Association Between Vitamin D and the Risk of Uterine Fibroids(ABVDATROUF) | unknown | N/A | 1,160 | Second Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Sep 5, 2018 | clinicaltrials |
| NCT00730886 | ExAblate Treatment of Uterine Fibroids for Fertility Enhancement | terminated | N/A | 2 | InSightecINDUSTRY | 1 | Aug 15, 2018 | clinicaltrials |
| NCT00166270 | MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids | completed | N/A | 70 | InSightecINDUSTRY | 1 | Jul 9, 2018 | clinicaltrials |
| NCT03550703 | Open Label Immunotherapy of Myoma(V3-myoma) | unknown | Phase 2 | 30 | Immunitor LLCINDUSTRY | 1 | Jul 6, 2018 | clinicaltrials |
| NCT00659360 | AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma | completed | Phase 2 | 17 | National Cancer Institute (NCI)NIH | 2 | Jun 29, 2018 | clinicaltrials |
| NCT01328067 | Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids | withdrawn | N/A | 0 | InSightecINDUSTRY | 1 | Jun 15, 2018 | clinicaltrials |
| NCT01992718 | What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography | completed | Early Phase 1 | 49 | University of MichiganOTHER | 1 | May 31, 2018 | clinicaltrials |
| NCT03509168 | The Efficacy and Safety of Preoperative Misoprostol in Blood-loss Reduction During Myomectomy.(MM) | unknown | Phase 2 / Phase 3 | 46 | Makerere UniversityOTHER | 1 | Apr 30, 2018 | clinicaltrials |
| NCT03500367 | Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis | unknown | Phase 4 | 25 | Peking Union Medical College HospitalOTHER | 1 | Apr 18, 2018 | clinicaltrials |
| NCT02059954 | Vaginal vs. Laparoscopic Hysterectomy | completed | N/A | 100 | Medical University of GrazOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT03219385 | Directed Ablation of Uterine Fibroids Using a Noninvasive Approach(DIANA) | unknown | N/A | 180 | Mirabilis Medica, Inc.INDUSTRY | 0 | Mar 21, 2018 | clinicaltrials |
| NCT03450421 | Safety and Efficacy of Actamax™Adhesion Barrier in Women Undergoing Laparoscopic Abdominopelvic Surgery/Myomectomy | unknown | N/A | 152 | Actamax Surgical Materials LLCINDUSTRY | 0 | Mar 1, 2018 | clinicaltrials |
| NCT02736435 | Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound | withdrawn | Phase 3 | 0 | Thunder Bay Regional Health Research InstituteOTHER | 1 | Feb 6, 2018 | clinicaltrials |
| NCT02192606 | Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?(3DRCT) | completed | N/A | 57 | Brigham and Women's HospitalOTHER | 2 | Jan 24, 2018 | clinicaltrials |
| NCT00995878 | The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids. | completed | Phase 4 | 56 | Mayo ClinicOTHER | 1 | Jan 12, 2018 | clinicaltrials |
| NCT01715597 | Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma | completed | Phase 3 | 50 | Seoul National University HospitalOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT01152112 | HOME Study: Hysteroscopic Office Myomectomy Evaluation(HOME) | completed | N/A | 74 | Hologic, Inc.INDUSTRY | 1 | Sep 13, 2017 | clinicaltrials |
| NCT01369758 | MyoSure Hysteroscopic Tissue Removal System Registry Study | completed | N/A | 290 | Hologic, Inc.INDUSTRY | 1 | Sep 13, 2017 | clinicaltrials |
| NCT02835391 | PerClot Compared to Usual Care in Gynaecology Procedures | completed | N/A | 90 | CryoLife EuropaINDUSTRY | 1 | Sep 1, 2017 | clinicaltrials |
| NCT01842789 | Post Market Evaluation of Acessa With TAG(TAG) | terminated | N/A | 18 | Acessa Health, Inc.INDUSTRY | 1 | Aug 18, 2017 | clinicaltrials |
| NCT02371811 | Use of v Care in Abdominal Hysterectomy | completed | N/A | 60 | Ain Shams Maternity HospitalOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT00332033 | Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) | completed | Phase 2 | 32 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01946178 | Clinical Study of the Mirabilis High-Intensity Focused Ultrasound System for Non-Invasive Treatment of Uterine Fibroids | completed | N/A | 73 | Mirabilis Medica, Inc.INDUSTRY | 1 | May 30, 2017 | clinicaltrials |
| NCT02633254 | Targeted Vessel Ablation of Type 3 Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound | terminated | N/A | 6 | UMC UtrechtOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT01504308 | Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids(SOFIA) | terminated | Phase 2 / Phase 3 | 49 | Philips HealthcareINDUSTRY | 3 | Apr 5, 2017 | clinicaltrials |
| NCT01936493 | Biologic Predictors of Leiomyoma Treatment Outcomes | completed | — | 38 | Elizabeth A. StewartOTHER | 1 | Mar 27, 2017 | clinicaltrials |
| NCT01971060 | a Study to Evaluate Adhesion Risk in Fertility Patients' Status Post Laparoscopic Myomectomy.(VLocmyo) | withdrawn | N/A | 0 | The Advanced Gynecologic Surgery InstituteOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT00031629 | Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus | completed | Phase 2 | 51 | Gynecologic Oncology GroupNETWORK | 1 | Dec 8, 2016 | clinicaltrials |
| NCT01852734 | Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives | completed | N/A | 52 | Odense University HospitalOTHER | 1 | Nov 28, 2016 | clinicaltrials |
| NCT02086344 | Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy | unknown | N/A | 167 | University Magna GraeciaOTHER | 1 | Nov 18, 2016 | clinicaltrials |
| NCT01388907 | Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery | completed | Phase 4 | 61 | Medtronic - MITGINDUSTRY | 1 | Nov 17, 2016 | clinicaltrials |
| NCT00897442 | Collecting Tumor Samples From Patients With Gynecological Tumors | completed | — | 275 | Gynecologic Oncology GroupNETWORK | 1 | Oct 28, 2016 | clinicaltrials |
| NCT02884960 | Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization | unknown | N/A | 118 | Gary Siskin, MDOTHER | 0 | Sep 1, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Jun 17, 2019source: clinicaltrials